Literature DB >> 15717656

Prostatic neuroendocrine tumor in multiple endocrine neoplasia Type 2B.

B Goulet-Salmon1, E Berthe, S Franc, S Chanel, F Galateau-Salle, M Kottler, J Mahoudeau, Y Reznik.   

Abstract

We report the unusual occurrence of a neuroendocrine prostatic tumor in two young males with multiple endocrine neoplasia (MEN) 2B. Immunohistochemistry of the tumor markers may help differentiate a primary neuroendocrine prostate tumor from the metastasis of a medullary thyroid carcinoma of poor prognosis. MEN 2B hallmarks (i.e. plasma thyrocalcitonin and urinary metanephrines) may be systematically investigated in neuroendocrine tumors of the prostate, and conversely prostate examination may be performed in the periodic screening of MEN 2B male patients.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15717656     DOI： 10.1007/BF03347481

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


  30 in total

1.  Calcitonin, katacalcin, and calcitonin gene-related peptide in the human prostate. An immunocytochemical and immunoelectron microscopic study.

Authors:  P A di Sant'Agnese; K L de Mesy Jensen; R K Ackroyd
Journal:  Arch Pathol Lab Med       Date:  1989-07       Impact factor: 5.534

2.  Partial characterization of a thyroid-stimulating hormone-like peptide in neuroendocrine cells of the human prostate gland.

Authors:  P A Abrahamsson; H Lilja
Journal:  Prostate       Date:  1989       Impact factor: 4.104

3.  Two cases of small cell carcinoma of the prostate.

Authors:  H Okada; A Gotoh; T Ogawa; S Arakawa; C Ohbayashi; S Kamidono
Journal:  Scand J Urol Nephrol       Date:  1996-12

4.  Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors.

Authors:  S N Agoff; L W Lamps; A T Philip; M B Amin; R A Schmidt; L D True; A L Folpe
Journal:  Mod Pathol       Date:  2000-03       Impact factor: 7.842

5.  Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas.

Authors:  W Cheuk; M Y Kwan; S Suster; J K Chan
Journal:  Arch Pathol Lab Med       Date:  2001-02       Impact factor: 5.534

6.  The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study.

Authors:  D S Schron; T Gipson; G Mendelsohn
Journal:  Cancer       Date:  1984-06-01       Impact factor: 6.860

7.  Somatostatin and/or somatostatin-like immunoreactive endocrine-paracrine cells in the human prostate gland.

Authors:  P A di Sant'Agnese; K L de Mesy Jensen
Journal:  Arch Pathol Lab Med       Date:  1984-09       Impact factor: 5.534

Review 8.  Primary carcinoid of the prostate in conjunction with multiple endocrine neoplasia IIb in a child.

Authors:  T Whelan; C T Gatfield; S Robertson; B Carpenter; J F Schillinger
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

9.  Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands.

Authors:  P A Abrahamsson; L B Wadström; J Alumets; S Falkmer; L Grimelius
Journal:  Pathol Res Pract       Date:  1986-12       Impact factor: 3.250

10.  The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain.

Authors:  D Lazzaro; M Price; M de Felice; R Di Lauro
Journal:  Development       Date:  1991-12       Impact factor: 6.868
View more
  5 in total

1.  Skip metastase on the left neck lymph nodes of the prostatic adenocarcinoma with neuroendocrine differentiation and accompanying thyroid micropapillary carcinoma.

Authors:  Levent Sagnak; Hikmet Topaloglu; Osman Gucuk; Unsal Han; Hamit Ersoy
Journal:  Pathol Oncol Res       Date:  2008-04-02       Impact factor: 3.201

Review 2.  Imaging of non-epithelial neoplasms of the prostate.

Authors:  Pankaj Nepal; Arpit Nagar; Sree Harsha Tirumani; Vijayanadh Ojili
Journal:  Abdom Radiol (NY)       Date:  2020-09-22

Review 3.  Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification.

Authors:  David S Priemer; Rodolfo Montironi; Lisha Wang; Sean R Williamson; Antonio Lopez-Beltran; Liang Cheng
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

4.  Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.

Authors:  Jonathan I Epstein; Mahul B Amin; Himisha Beltran; Tamara L Lotan; Juan-Miguel Mosquera; Victor E Reuter; Brian D Robinson; Patricia Troncoso; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

Review 5.  Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms.

Authors:  William Butler; Jiaoti Huang
Journal:  Precis Clin Med       Date:  2021-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.